Allianz Asset Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-148,775	Closed	-$14.5M	–	2120
2015 Q1	$14.5M	Sell	148,775 -62,870	-30%	-$6.13M	0.02%	704
2014 Q4	$19.6M	Buy	211,645 +80,540	+61%	+$7.47M	0.02%	620
2014 Q3	$9.02M	Buy	131,105 +41,325	+46%	+$2.84M	0.01%	787
2014 Q2	$9.41M	Buy	+89,780	New	+$9.41M	0.01%	744